Reed Brent N, Devabhakthuni Sandeep
Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore.
Crit Care Nurs Q. 2017 Oct/Dec;40(4):363-373. doi: 10.1097/CNQ.0000000000000173.
Most patients with acute decompensated heart failure (ADHF) present with signs and symptoms of volume overload, and those with a significant history of diuretic exposure may demonstrate varying degrees of diuretic resistance. Although this phenomenon is commonly reported, no consensus definition exists and recommendations regarding an optimal therapeutic approach remain limited. Optimizing the use of intravenous (IV) loop diuretic therapy is the most common initial approach, and therapy may be augmented by the addition of a thiazide-type diuretic or an IV vasodilator. Patients whose resistance to diuretic therapy is due to low cardiac output may require inotropic therapy, and other options (eg, ultrafiltration and vasopressin antagonists) may be considered in select populations. The purpose of this review is to describe diuretic resistance and its underlying mechanisms in ADHF, as well as the most commonly employed strategies for overcoming it. A stepwise approach to managing volume overload in patients with ADHF and diuretic resistance is also provided.
大多数急性失代偿性心力衰竭(ADHF)患者表现出容量超负荷的体征和症状,而那些有大量利尿剂使用史的患者可能表现出不同程度的利尿剂抵抗。尽管这种现象经常被报道,但尚无共识性定义,关于最佳治疗方法的建议也仍然有限。优化静脉注射(IV)袢利尿剂治疗是最常见的初始方法,可通过加用噻嗪类利尿剂或静脉血管扩张剂来增强治疗效果。因心输出量低而对利尿剂治疗产生抵抗的患者可能需要使用正性肌力药物治疗,在特定人群中可考虑其他选择(如超滤和血管加压素拮抗剂)。本综述的目的是描述ADHF中利尿剂抵抗及其潜在机制,以及最常用的克服利尿剂抵抗的策略。还提供了一种逐步管理ADHF和利尿剂抵抗患者容量超负荷的方法。